Literature DB >> 15919314

The off-pump Fontan procedure by simply cross-clamping the inferior caval vein.

Shuichi Shiraishi1, Hideki Uemura, Koji Kagisaki, Masahiro Koh, Toshikatsu Yagihara, Soichiro Kitamura.   

Abstract

BACKGROUND: We previously used the Fontan procedure, when applicable, by placing a temporary bypass from the inferior vena cava to the atrium. Alternatively, we have striven to achieve the procedure even without use of a temporary bypass in patients having collaterals between the inferior vena cava and the superior vena cava, so as to simplify the procedure. The azygous vein was intentionally left patent at the bidirectional Glenn procedure in the most recent 9 patients, expecting reasonable venovenous communication at Fontan completion. Surgical results will be described for the preliminary experience.
METHODS: Since 2001, this alternative technique has been attempted in 34 patients undergoing the staged Fontan procedure, and eventually used in 22. Duration between the staged procedures was 4 to 108 months (median, 10 months). We considered that the technique was feasible unless femoral venous pressure exceeded 20 mm Hg immediately after cross-clamping the inferior vena cava. Although catheterization before the Fontan completion illustrated development of venovenous collaterals in 14 patients, oxygen saturation remained greater than 80% throughout the period of the bidirectional Glenn physiology.
RESULTS: In all 22 patients, the extracardiac channel was readily reconstructed with an excellent surgical field of view, without operative mortality. On cross-clamping the inferior vena cava, the systemic circulation could be well maintained by administration of dopamine. Oxygen saturation immediately became approximately 97% to 100%. Maximal pressure gradient was 11 +/- 5 mm Hg between the superior vena cava and the femoral vein. Postoperatively, serum concentration of enzymes did not critically increase (maximal aspartate transaminase, 96 +/- 89 U/L; alanine transaminase, 65 +/- 59 U/L; total bilirubin, 1.8 +/- 1.1 mg/dL; creatine kinase, 437 +/- 230 U/L).
CONCLUSIONS: This alternative technique, when feasible under the current criteria, was simple and did not provide any clinically significant impediments.

Entities:  

Mesh:

Year:  2005        PMID: 15919314     DOI: 10.1016/j.athoracsur.2004.11.056

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Long-term results of total cavopulmonary connection with low ejection fraction.

Authors:  Shuichi Shiraishi; Hideki Uemura; Koji Kagisaki; Ikuo Hagino; Junjiro Kobayashi; Masashi Takahashi; Toshikatsu Yagihara
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-10-08

2.  Miniaturized biocompatible cardiopulmonary bypass for the Fontan procedure.

Authors:  Keiichi Itatani; Kagami Miyaji; Takashi Miyamoto; Nobuyuki Inoue; Takahiro Tomoyasu; Satoshi Kohira; Hajime Sato; Kuniyoshi Ohara
Journal:  Surg Today       Date:  2010-11-03       Impact factor: 2.549

3.  Staged Fontan operation for children with heterotaxy syndrome, bilateral ductus arteriosus, and nonconfluent pulmonary artery.

Authors:  Shinya Kanemoto; Masakazu Abe; Yukiko Ban; Seigo Gomi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-07-14

4.  Early results of the "clamp and sew" Fontan procedure without the use of circulatory support.

Authors:  Takeshi Shinkawa; Petros V Anagnostopoulos; Natalie C Johnson; Laura Presnell; Naruhito Watanabe; Anil Sapru; Anthony Azakie
Journal:  Ann Thorac Surg       Date:  2011-05       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.